Zdrowie i gospodarka · 31.01.1994
Opportunity for a License: Assay To Screen Inhibitors of HIV-1 Aspartyl Protease
The National Institutes of Health seeks to license a novel radiometric assay system for identifying new anti-retroviral drugs targeting HIV-1 aspartyl proteinase.